Lockerman Financial Group Inc. Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Lockerman Financial Group Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 925 shares of the healthcare conglomerate’s stock after buying an additional 29 shares during the period. UnitedHealth Group makes up approximately 1.1% of Lockerman Financial Group Inc.’s investment portfolio, making the stock its 24th largest holding. Lockerman Financial Group Inc.’s holdings in UnitedHealth Group were worth $487,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Robbins Farley purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $25,000. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of UnitedHealth Group during the first quarter worth $35,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on UNH. Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Royal Bank of Canada reissued an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Piper Sandler reduced their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Barclays assumed coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target on the stock. Finally, HSBC reissued a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.60 during midday trading on Thursday, reaching $494.70. 3,805,551 shares of the company traded hands, compared to its average volume of 4,097,774. The company has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a 50-day moving average price of $503.10 and a 200 day moving average price of $518.61. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter last year, the business earned $5.34 earnings per share. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.